In this issue: Science News | Current Publications | Industry News | Policy News  | Events Subscribe | Unsubscribe


TOP STORIES

Stopping Tissue Stiffening is Key to Preventing Aggressive Cancers
Scientists have identified an enzyme that is crucial for turning abnormal but non-malignant breast tissue into tumours.  [University of California, San Francisco]

DissociationEnzymes_645x110_v01


SCIENCE NEWS

Protein from Pregnancy Hormone May Prevent Breast Cancer
Hormones produced during pregnancy induce a protein that directly inhibits the growth of breast cancer.  [Albany Medical College, New York]

New Gene Discovered That Increases the Effectiveness of Drugs Used to Fight Cancer and Allows a Reduction in Dosage
Researchers at the University of Granada have found a suicide gene, called 'gene E', which leads to the death of tumour cells derived from breast, lung and colon cancer, and prevents their growth.  [University of Granada, Granada]

Researchers Identify Role of Gene in Tumor Development, Growth and Progression
Researchers have identified a gene that may play a pivotal role in two processes that are essential for tumor development, growth and progression to metastasis. [Massey Cancer Center, Richmond]

Breast Cancer Research Funding to Establish Effectiveness of Radiotherapy
£160,000 has been granted to study how genes are involved in the effectiveness of radiotherapy treatment for breast cancer.  [Queen's University, Belfast]


MammoCultBreastCancer_645x110_v01




CURRENT PUBLICATIONS

LABORATORY RESEARCH

Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling
Study shows how collagen crosslinking can modulate tissue fibrosis and stiffness to force focal adhesions, growth factor signaling and breast malignancy. [Cell]

C-Jun Activation is Required for 4-Hydroxytamoxifen-Induced Cell Death in Breast Cancer Cells
Study results indicate that the c-Jun/c-Fos AP-1 complex has a pro-apoptotic role in OHT-treated cancer cells and suggest that pharmacological boosts of c-Jun activation may be useful in a combination therapy setting to sensitize cancer cells to tamoxifen-mediated cell death. [Oncogene]

MBP-1 Inhibits Breast Cancer Growth and Metastasis in Immunocompetent Mice
Study shows that MBP-1 acts as a double-edged sword by inhibiting primary and metastatic tumor growth and modulating matrix metalloproteinase expression with a therapeutic potential against breast cancer progression. [Cancer Res]

Confounding Effects in "A Six-Gene Signature Predicting Breast Cancer Lung Metastasis"
Research shows that the six-gene signature predicts lung metastases of breast tumors independent of the molecular subtypes. [Cancer Res]

Invasion of Human Breast Cancer Cells In vivo Requires Both Paracrine and Autocrine Loops Involving the Colony-Stimulating Factor-1 Receptor
This investigation demonstrates for the first time in vivo that invasion in a human mammary tumor model is dependent on both paracrine signaling with host macrophages as well as autocrine signaling involving the tumor cells themselves. [Cancer Res]

CLINICAL RESEARCH

Circulating Carotenoids, Mammographic Density, and Subsequent Risk of Breast Cancer
Research results suggest that plasma levels of carotenoids may play a role in reducing breast cancer risk, particularly among women with high mammographic density. [Cancer Res]

Prognosis of Women with Metastatic Breast Cancer by HER2 Status and Trastuzumab Treatment: An Institutional-Based Review
Research model suggests that women with HER2/neu-positive disease who received trastuzumab had a 44% reduction in the risk of death compared with women with HER2/neu-negative disease.  [J Clin Oncol]

EpiCultBHuman_645x110_v01




INDUSTRY NEWS

Cytori Completes Enrollment in International Breast Cancer Reconstruction Study; Interim Data to be Presented Dec. 12 at San Antonio Breast Cancer Symposium
The study is evaluating the use of cell-enriched fat grafting to restore functional and cosmetic deformities in women who have undergone partial mastectomy for early breast cancer.




POLICY NEWS

NIGMS 'Challenge' Areas Get Millions in Recovery Act Funds
The National Institute of General Medical Sciences (NIGMS) has invested $16.4 million of American Recovery and Reinvestment Act (Recovery Act) funds to jump-start a range of research projects that address critical gaps in the basic biomedical and behavioral sciences.


EVENTS

32nd Annual CTRC - AACR San Antonio Breast Cancer Symposium
December 9-13, 2009
San Antonio, TX

Gordon Research Conference - Mammary Gland Biology
June 6-11, 2010
Lucca (Barga), Italy

12th Milan Breast Cancer Conference
June 16-18, 2010
Milan, Italy

The 21st Meeting of the European Association for Cancer Research
June 26-29, 2010
Oslo, Norway

Visit our events page to stay up to date with the latest events in the cell, gene and immunotherapy community.



JOB OPPORTUNITIES

Manager, Market Segment Regenerative Medicine (Sigma-Aldrich Corporation)

Technical Specialist (AABB)

R&D Scientist (STEMCELL Technologies)

Recruit Top Talent
Reach more than 11,000 potential candidates by posting your organization's career opportunities with Cell Therapy News.
Visit here to post your career opportunities.


Have we missed an important article or publication in Mammary Cell News? Click here to submit!

 
forwardafriendicon

Learn more about Mammary Cell News: Archives | Events | Update Profile | Contact Us
This email was sent by: Connexon Creative
400-570 W. 7th Avenue Vancouver, British Columbia V5Z 1B3 Canada